Unfortunately there was an error in the entry for selexipag in table 2 of this article. Instead of “none” for background therapy it should have stated “‘none, ERA, PDE-5i or both’”. Please find the corrected table below.
View this table:
TABLE 2
Key randomised controlled clinical trials of drugs that target the prostacyclin pathway
- Copyright ©ERS 2017. ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Vol 26 Issue 143
Table of Contents
“Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.” Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630–641.
